HOME >> BIOLOGY >> NEWS
ORNL technology gets nod from EPA

OAK RIDGE, Tenn., April 19, 2002 - Prospects for cleaning up contaminated sites around the country are better because of a technology and procedure developed at the Department of Energys Oak Ridge National Laboratory and recently accepted by the Environmental Protection Agency.

The technology, which consists of direct sampling and analysis of volatile organic compounds in water, soil, gas and air, requires little if any sample preparation and yields results in three to five minutes. Compared to conventional approaches, the method saves time, money and allows more sites to be tested -- and ultimately decontaminated.

"EPA's official acceptance of this method should accelerate its adoption by the regulatory community," said Roger Jenkins of the Chemical Sciences Division. "Before that happened, there would have been only modest interest in using this procedure to support on-site characterization and remediation."

With direct sampling ion trap mass spectrometry, the person conducting the test introduces sample materials directly into an ion trap mass spectrometer through a simple interface. No chromatographic separation is required, and the response of the instrument is nearly instantaneous. EPA's new Method 8265, developed by ORNL, embodies this technique.

"The implication of the EPA's having made this direct sampling and analysis methodology an official method is that regulators are now much more likely to accept this new rapid method performed in the field as being 'just as good' as a standard fixed laboratory procedure," said Marcus Wise, a scientist in ORNL's Chemical Sciences Division and one of the developers of the instrument and methodology. "With the budget constraints, it has become increasingly important to develop and deploy innovative technologies for faster and less expensive approaches to restore the environment."

Tri-Corders Environmental of McLean, Va., has licensed the technology from ORNL and is building transp
'"/>

Contact: Ron Walli
wallira@ornl.gov
865-576-0226
DOE/Oak Ridge National Laboratory
19-Apr-2002


Page: 1 2

Related biology news :

1. Yale digital diagnostic technology is basis of new company, HistoRx Inc.
2. AACR applauds NCI initiative on nanotechnology
3. Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies
4. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
5. Researchers show how to assemble building blocks for nanotechnology
6. Jefferson Lab detector technology aids development of cystic fibrosis therapy
7. National Academies Advisory: Sept. 18-19 Nanotechnology Conference
8. New diagnostic technology helps justify earlier cataract surgery
9. New textbook introduces students to the foundations, applications of nanotechnology
10. UK biotechnology business plan competition now open to students in the US and Canada
11. The future of nanotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ORNL technology gets nod from EPA

(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
(Date:5/21/2013)... of biomass experts , Where? Copenhagen, ... 03-07 June 2013 , Why? ... assessment, market and policy developments, manufacturing and installation, drawing ... benefiting from its 2013 edition from a record of ... countries, more than 240 plenary and oral presentations, more ...
(Date:5/21/2013)... ANDOVER, Mass. , May 21, 2013 ... that CX50 xMATRIX, the world,s first portable ultrasound with ... Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available ... Paris at the EuroPCR, official ... (EAPCI), May 21-24. Since its launch in ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
(Date:5/21/2013)... May 21, 2013  MacroGenics, Inc. today announced ... margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), ... HER2 oncoprotein," will be presented at the 2013 ... Oncology during the Developmental Therapeutics - Immunotherapy Oral ... – 4:30 PM.  The presentation will describe the ...
(Date:5/21/2013)... 21, 2013  Personal Genome Diagnostics Inc. (PGDx), ... methodologies and expertise in genomic analysis of defined ... collaboration with Blueprint Medicines.  PGDx is an innovator ... alterations in tumors, and Blueprint Medicines is an ... a genetically defined patient population. "This ...
(Date:5/21/2013)... Minneapolis, MN (PRWEB) May 21, 2013 ... a patented automatic colony counter, announced today that they ... four products , the IncuCount, IntelliCount, InCount and ... price and sophistication are especially useful in food microbiology ... been given an updated look. A bright white ...
(Date:5/21/2013)... Mississauga, Ontario (PRWEB) May 21, 2013 ... expert scientists of the ITN to design the ... usefulness of two key clinical models used in ... Chamber (EEC) and Nasal Allergen Challenge (NAC) models. ... supported by numerous publications, to date no direct ...
Breaking Biology Technology:MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2
Cached News: